Related references
Note: Only part of the references are listed.Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications
Theodore Kelesidis et al.
ANNALS OF INTERNAL MEDICINE (2010)
Drug-induced lipotoxicity: Lipodystrophy associated with HIV-1 infection and antiretroviral treatment
Francesc Villarroya et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Leptin therapy in lipodystrophy
D. B. Savage et al.
DIABETOLOGIA (2010)
Efficacy of leptin therapy in the different forms of human lipodystrophy
A. Y. Chong et al.
DIABETOLOGIA (2010)
RATIONALE FOR LEPTIN-REPLACEMENT THERAPY FOR SEVERE LIPODYSTROPHY
Elif A. Oral et al.
ENDOCRINE PRACTICE (2010)
Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin
Jacques Beltrand et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Inhibition of Mitochondrial Function by Efavirenz Increases Lipid Content in Hepatic Cells
Ana Blas-Garcia et al.
HEPATOLOGY (2010)
A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy
Janet M. Raboud et al.
HIV CLINICAL TRIALS (2010)
Effects of Tesamorelin, a Growth Hormone-Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension
Julian Falutz et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Higher Adiponectin Levels in Patients with Berardinelli-Seip Congenital Lipodystrophy due to Seipin as compared with 1-Acylglycerol-3-Phosphate-O-Acyltransferase-2 Deficiency
Barbara Antuna-Puente et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy
Regje ME Blümer et al.
AIDS (2009)
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
Richard H. Haubrich et al.
AIDS (2009)
Assessment of Ultrasound for Use in Detecting Lipoatrophy in HIV-Infected Patients Taking Combination Antiretroviral Therapy
Klaudija Viskovic et al.
AIDS PATIENT CARE AND STDS (2009)
Lipodystrophies: Disorders of adipose tissue biology
Abhimanyu Garg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
Seipin deficiency alters fatty acid Δ9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy
Emilie Boutet et al.
BIOCHIMIE (2009)
Molecular Mechanisms of Hepatic Steatosis and Insulin Resistance in the AGPAT2-Deficient Mouse Model of Congenital Generalized Lipodystrophy
Victor A. Cortes et al.
CELL METABOLISM (2009)
Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: A case report
C. Collet-Gaudillat et al.
DIABETES & METABOLISM (2009)
Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC
Oscar Rubio-Cabezas et al.
EMBO MOLECULAR MEDICINE (2009)
Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report
Jianyong Wu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans
Aoife M. Brennan et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Adherence to the Mediterranean diet is associated with a lower risk of body-shape changes in Croatian patients treated with combination antiretroviral therapy
Drago Turcinov et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2009)
HIV-1 Protease Inhibitor Induced Oxidative Stress Suppresses Glucose Stimulated Insulin Release: Protection with Thymoquinone
Surabhi Chandra et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand
B. Lee et al.
HIV MEDICINE (2009)
The Effect of Rosiglitazone on Insulin Sensitivity, Beta Cell Function, Bone Mineral Density, and Body Composition in HIV-positive Patients on Highly-active Antiretroviral Therapy (HAART)
K. Schindler et al.
HORMONE AND METABOLIC RESEARCH (2009)
The Effect of Individual Antiretroviral Drugs on Body Composition in HIV-Infected Persons Initiating Highly Active Antiretroviral Therapy
Judith C. Shlay et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Whither Recombinant Human Leptin Treatment for HIV-Associated Lipoatrophy and the Metabolic Syndrome?
Christos S. Mantzoros
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Effects of Recombinant Human Leptin on Visceral Fat, Dyslipidemia, and Insulin Resistance in Patients with Human Immunodeficiency Virus-Associated Lipoatrophy and Hypoleptinemia
Kathleen Mulligan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy
Yukiko K. Hayashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Gene Expression and Immunohistochemistry in Adipose Tissue of HIV Type 1-Infected Patients with Nucleoside Analogue Reverse-Transcriptase Inhibitor-Associated Lipoatrophy
M. Sievers et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders
Isabelle Mercier et al.
LABORATORY INVESTIGATION (2009)
Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions
Donald P. Kotler
LIVER INTERNATIONAL (2009)
Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy
Masanori Iwanishi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Adherence to Mediterranean diet is favorably associated with metabolic parameters in HIV-positive patients with the highly active antiretroviral therapy-induced metabolic syndrome and lipodystrophy
Sotiris Tsiodras et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
GH/GHRH axis in HIV lipodystrophy
Takara L. Stanley et al.
PITUITARY (2009)
Long term adverse effects related to nucleoside reverse transcriptase inhibitors: Clinical impact of mitochondrial toxicity
Anne Maagaard et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2009)
Genetic analysis implicates resistin in HIV lipodystrophy
Koustubh Ranade et al.
AIDS (2008)
Metformin Increases HDL3-Cholesterol and Decreases Subcutaneous Truncal Fat in Nondiabetic Patients with HIV-Associated Lipodystrophy
Leandro A. Diehl et al.
AIDS PATIENT CARE AND STDS (2008)
Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability
Vinaya Simha et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy
Ksenia Sevastianova et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Leptin therapy for partial lipodystrophy linked to a PPAR-γ mutation
[Anonymous]
CLINICAL ENDOCRINOLOGY (2008)
Pharmacokinetics of Subcutaneous Recombinant Methionyl Human Leptin Administration in Healthy Subjects in the Fed and Fasting States Regulation by Gender and Adiposity
Jean L. Chan et al.
CLINICAL PHARMACOKINETICS (2008)
The human lipodystrophy gene BSCL2/Seipin may be essential for normal adipocyte differentiation
Victoria A. Payne et al.
DIABETES (2008)
Prolonged thiazolidinedione therapy does not reverse fat loss in patients with familial partial lipodystrophy, Dunnigan variety
V. Simha et al.
DIABETES OBESITY & METABOLISM (2008)
Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin
A. Gambineri et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
AdipoR1 mediates the anorexigenic and insulin/leptin-like actions of adiponectin in the hypothalamus
Andressa Coope et al.
FEBS LETTERS (2008)
Treatment of altered body composition in HIV-associated lipodystrophy: Comparison of rosiglitazone, pravastatin, and recombinant human growth hormone
Derek C. Macallan et al.
HIV CLINICAL TRIALS (2008)
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV
J. D. Lundgren et al.
HIV MEDICINE (2008)
Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation - A randomized controlled trial
Janet Lo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options
Jane E. Mallewa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Approach to the human immunodeficiency virus-infected patient with lipodystrophy
Todd T. Brown
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy
B. Lindegaard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy
M. C. Vantyghem et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy
C. A. Kim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
LANCET (2008)
Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor γ and inhibits adipocyte differentiation:: Implications for HIV-associated lipodystrophy
Shashi Shrivastav et al.
MOLECULAR ENDOCRINOLOGY (2008)
Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia
Henian Cao et al.
LIPIDS IN HEALTH AND DISEASE (2008)
Acquired partial lipodystrophy in an 11-year-old girl
Joanna Oswiecimska et al.
PEDIATRICS INTERNATIONAL (2008)
Metabolic effects of a growth hormone-releasing factor in patients with HIV
Julian Falutz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Rosiglitazone increases small dense low-density lipoprotein concentration and decreases high-density lipoprotein particle size in HIV-infected patients
Colleen Hadigan et al.
AIDS (2007)
Efficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report
F. Moreau et al.
DIABETES & METABOLISM (2007)
Founder effect of the 669insA mutation in BSCL2 gene causing Berardinelli-Seip congenital lipodystrophy in a cluster from Brazil
K. B. Gomes et al.
ANNALS OF HUMAN GENETICS (2007)
Lipids in health and disease
Kevin W. Johns et al.
LIPIDS IN HEALTH AND DISEASE (2007)
Adipose tissue integrity as a prerequisite for systemic energy balance -: A critical role for peroxisome proliferator-activated receptor γ
Silvia I. Anghel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tumour necrosis factor-α in human adipose tissue -: from signalling mechanisms to clinical implications
M. Ryden et al.
JOURNAL OF INTERNAL MEDICINE (2007)
A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy
R. Kohli et al.
HIV MEDICINE (2007)
Leisure time physical activity prevents accumulation of central fat in HIV/AIDS subjects on highly active antiretroviral therapy
Alex Antonio Florindo et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2007)
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials
Rodrigo M. Lago et al.
LANCET (2007)
Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy
Jacques Beltrand et al.
PEDIATRICS (2007)
A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy
Rodrigo B. Cavalcanti et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Pharmacokinetics of recombinant methionyl human leptin after subcutaneous administration: Variation of concentration-dependent parameters according to assay
Jean L. Chan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The role of adipokines in relation to HIV lipodystrophy
Laura L. Sweeney et al.
AIDS (2007)
Obesity, inflammation, and insulin resistance
Steven E. Shoelson et al.
GASTROENTEROLOGY (2007)
Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-γ
Houshang Monajemi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy
Jean Y. Park et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to zidovudine
Rao L. Divi et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2007)
Hypotension, lipodystrophy, and insulin resistance in generalized PPARγ-deficient mice rescued from embryonic lethality
Sheng Zhong Duan et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Muscle and nerve pathology in Dunnigan familial partial lipodystrophy
S. Spuler et al.
NEUROLOGY (2007)
Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy
Ken Ebihara et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Effectiveness of subcutaneous growth hormone in HIV-1 patients with moderate to severe facial lipoatrophy
Miwako Honda et al.
INTERNAL MEDICINE (2007)
Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men
Subhashini Yaturu et al.
DIABETES CARE (2007)
Analysis of genetic variation in Akt2/PKB-beta in severe insulin resistance, lipodystrophy, type 2 diabetes, and related metabolic phenotypes
Karen Tan et al.
DIABETES (2007)
Childhood acquired lipodystrophy: A retrospective study
Elena Pope et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia
Colleen Hadigan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy
M. Bickel et al.
HIV MEDICINE (2006)
Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs
Monia Pacenti et al.
AIDS (2006)
Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy
Robert A. Hegele et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients
Blai Coll et al.
AIDS (2006)
Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy
Jennifer H. Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men - a randomized, placebo-controlled study
Patrick W. G. Mallon et al.
AIDS (2006)
Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome
T. Feldt et al.
INFECTION (2006)
Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG study A5108
JA Aberg et al.
AIDS (2006)
Exercise training in HIV-1-infected individuals with dyslipidemia and lipodystrophy
L Terry et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2006)
Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy
RL Boguslavsky et al.
HUMAN MOLECULAR GENETICS (2006)
Strategies for management and treatment of dyslipidemia in HIV/AIDS
PE Sax
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2006)
Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy
EA Oral et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults:: A longitudinal study
AY McDermott et al.
CLINICAL INFECTIOUS DISEASES (2005)
GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled study
L Luzi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Long-term treatment experience in a subject with Dunnigan-type familial partial lipodystrophy:: efficacy of rosiglitazone
A Lüdtke et al.
DIABETIC MEDICINE (2005)
Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis
RB Ceddia
INTERNATIONAL JOURNAL OF OBESITY (2005)
Comparison of rosiglitazone and metformin for treating HIV lipodystrophy - A randomized trial
JPH van Wijk et al.
ANNALS OF INTERNAL MEDICINE (2005)
A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation
J Falutz et al.
AIDS (2005)
Impact of rosiglitazone treatment on the bioavailability of antiretroviral compounds in HIV-positive patients
M Oette et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy
M Shah et al.
HIV MEDICINE (2005)
Long-term efficacy of leptin replacement in patients with generalized lipodystrophy
ED Javor et al.
DIABETES (2005)
Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin - Results of AIDS clinical trials group 5108 study
JG Gerber et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy
ED Javor et al.
HEPATOLOGY (2005)
The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients
C Musso et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Medical progress - Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
S Grinspoon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes
K El Hadri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy
SA Moran et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
HIV infection, HAART, and endothelial adhesion molecules: current perspectives
KD Donati et al.
LANCET INFECTIOUS DISEASES (2004)
Medical progress - Acquired and inherited lipodystrophies
A Garg
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients
SD Driscoll et al.
AIDS (2004)
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial
A Carr et al.
LANCET (2004)
Adiponectin ameliorates dyslipidemia induced by the human immunodeficiency virus protease inhibitor ritonavir in mice
AM Xu et al.
ENDOCRINOLOGY (2004)
Site and mechanism of leptin action in a rodent form of congenital lipodystrophy
E Asilmaz et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy
JA Johnson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency
JR McDuffie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy
MT Gerber et al.
CLINICAL INFECTIOUS DISEASES (2004)
Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot study
O Andersen et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Adiponectin: Novelties in metabolism and hormonal regulation
LH Duntas et al.
NUTRITIONAL NEUROSCIENCE (2004)
Growth hormone-releasing hormone in HIV-infected men with lipodystrophy - A randomized controlled trial
P Koutkia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: Baseline characteristics and course during recombinant leptin therapy
ED Javor et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Leptin hormonal kinetics in the fed state: Effects of adiposity, age, and gender on endogenous leptin production and clearance rates
SL Wong et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Mutations in the Seipin and AGPAT2 genes clustering in consanguineous families with Berardinelli-Seip congenital lipodystrophy from two separate geographical regions of Brazil
KB Gomes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Fenofibrate is effective in treating hypertriglyceridemia associated with HIV lipodystrophy
A Rao et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2004)
Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy - Report of 35 cases and review of the literature
A Misra et al.
MEDICINE (2004)
Lipodystrophies: rare disorders causing metabolic syndrome
A Garg et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2004)
A family with severe insulin resistance and diabetes due to a mutation in AKT2
S George et al.
SCIENCE (2004)
Metabolic effects of rosiglitazone in HIV lipodystrophy - A randomized, controlled trial
C Hadigan et al.
ANNALS OF INTERNAL MEDICINE (2004)
Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene
KR Owen et al.
DIABETIC MEDICINE (2003)
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy:: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
MP Dubé et al.
CLINICAL INFECTIOUS DISEASES (2003)
Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia
AK Agarwal et al.
HUMAN MOLECULAR GENETICS (2003)
Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy
C Vigouroux et al.
AIDS (2003)
Exercise and vitamin E intake are independently associated with metabolic abnormalities in human immunodeficiency virus-positive subjects: A cross-sectional study
A Gavrila et al.
CLINICAL INFECTIOUS DISEASES (2003)
Kobberling type of familial partial lipodystrophy - An underrecognized syndrome
KL Herbst et al.
DIABETES CARE (2003)
Human immunodeficiency virus/highly active antiretroviral therapy-associated metabolic syndrome: Clinical presentation, pathophysiology, and therapeutic strategies
MKS Leow et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Regulation of adiponectin in human immunodeficiency virus-infected patients:: Relationship to body composition and metabolic indices
Q Tong et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin
GS Nagy et al.
CLINICAL INFECTIOUS DISEASES (2003)
Clinical features and metabolic derangements in acquired generalized lipodystrophy - Case reports and review of the literature
A Misra et al.
MEDICINE (2003)
Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy
CL Addy et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Tumour necrosis factor-alpha gene-238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy
D Nolan et al.
AIDS (2003)
Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or Seipin genes
V Simha et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?
D Nolan et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2003)
Adiponectin and leptin levels in HIV-Infected subjects with insulin resistance and body fat redistribution
DC Mynarcik et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2002)
Comparison of gemfibrozil and Fenofibrate in patients with dyslipidemic coronary heart disease
KA Packard et al.
PHARMACOTHERAPY (2002)
A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia
J Miller et al.
AIDS (2002)
Sustained benefits of metformin therapy on markers of cardiovascular risk in human immunodeficiency virus-infected patients with fat redistribution and insulin resistance
C Hadigan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: A pilot study
MC Gelato et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2002)
Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy
C Hadigan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
Measuring body fat distribution and content in humans
BH Goodpaster
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2002)
Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy
C Colombo et al.
DIABETES (2002)
Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C
G Novelli et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Serum adiponectin and leptin levels in patients with lipodystrophies
WA Haque et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34
AK Agarwal et al.
NATURE GENETICS (2002)
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047
CJ Fichtenbaum et al.
AIDS (2002)
Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities
B Razani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Leptin-replacement therapy for lipodystrophy
EA Oral et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
American Diabetes Association Position Statement: Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications
MJ Franz et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2002)
A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy
AK Agarwal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Short-term exercise training improves body composition and hyperlipidaemia in HIV-positive individuals with lipodystrophy
SP Jones et al.
AIDS (2001)
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
T Yamauchi et al.
NATURE MEDICINE (2001)
Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13
J Magré et al.
NATURE GENETICS (2001)
Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes
K Ebihara et al.
DIABETES (2001)
Metformin in the treatment of HIV lipodystrophy syndrome - A randomized controlled trial
C Hadigan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Mechanism of insulin resistance in A-ZIP/F-1 fatless mice
JK Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety)
A Garg
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
O Gavrilova et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy
H Cao et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
